ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancer patients as experimental drug enters human trials
Disease control Recruiting nowThis study tests an experimental drug called MHB009C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants receive the drug alone, and researchers monitor side e…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
Modified virus takes on Hard-to-Treat tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called VG2062, which is a modified virus designed to attack cancer cells. It is for people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety and find the best dose for f…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Shanghai Virogin Biotech Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug combo targets advanced cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests whether combining two experimental drugs, MHB036C and MHB039A, can shrink or control advanced breast cancer and other solid tumors that have spread. About 210 adults aged 18 to 75 with measurable tumors will receive the combination. The goal is to see if the trea…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 12, 2026 13:44 UTC
-
New hope for advanced cancer: experimental drug MHB048C enters human trials
Disease control Recruiting nowThis study tests a new drug called MHB048C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. Participants receive the drug by IV and are monitored for side effects and tumor re…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New immune therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called RPTR-1-201, which helps the immune system attack cancer cells. It is for adults with advanced solid tumors that cannot be cured with standard treatments. The study will check safety and whether the drug shrinks tumors, both alone and…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Repertoire Immune Medicines • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New hope for advanced cancer patients? early trial of MHB042C begins
Disease control Recruiting nowThis study tests a new drug called MHB042C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug intravenously and be closely monitored for…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests two experimental drugs, MHB088C and MHB039A, given together to people with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. About 116 adults will take part in t…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New cancer drug PLT012 enters human testing for advanced tumors
Disease control Recruiting nowThis early-phase study tests the safety and best dose of a new drug called PLT012 in adults with advanced solid tumors that have not responded to other treatments. About 36 participants will receive the drug by IV every three weeks. The study will monitor side effects, drug level…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Pilatus Biosciences Inc • Aim: Disease control
Last updated May 04, 2026 16:30 UTC